This hypothesis is further supported by our data showing that MM cells treated with hemin or CO, a substrate and a by-product, respectively, of HO-1 enzymatic activity, increased TLR4 expression and activated its downstream signaling. The gene discussed is TLR4; the disease is Miyoshi myopathy.